Celldex Therapeutics, Inc.
CLDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000744218
No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Celldex Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 132 | 1 | 161 | +30 |
| Shares | 35.3M | 333 | 43.0M | +7.72M (+21.9%) |
| Value | $1.19B | $11.0K | $2.33B | +$1.14B (+95.6%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (44)
Institutions that held Celldex Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (14)
Institutions that held Celldex Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Cresset Asset Management, LLC | 457,666 | $15.3M |
| Tri Locum Partners LP | 175,305 | $5.86M |
| DSAM Partners (London) Ltd | 135,907 | $4.54M |
| Two Sigma Advisers, LP | 87,736 | $2.93M |
| Jump Financial, LLC | 51,400 | $1.72M |
| Norges Bank | 32,200 | $1.08M |
| Raymond James Financial Services Advisors, Inc. | 15,180 | $508.0K |
| FORA Capital, LLC | 9,861 | $330.0K |
| Gsa Capital Partners LLP | 9,769 | $327.0K |
| Lazard Asset Management LLC | 7,075 | $236.0K |
| Tekla Capital Management LLC | 7,053 | $236.0K |
| Panagora Asset Management Inc | 1,150 | $38.0K |
| Enterprise Financial Services Corp | 90 | $3.00K |
| Advisory Services Network, LLC | 17 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Celldex Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Horizon Corp | 333 | $11.0K |